Citations

Showing 10 of 108081 citations.

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study
Jaafari, Hussain, Houghton, Lesley A. , West, Robert , Aziz, Imran , Black, Christopher J. , Corsetti, Maura , Shuweihdi, Farag , Eugenicos, Maria , Paine, Peter , Ford, Alexander C. , Whorwell, Peter J. , Palsson, Olafur S. , Vasant, Dipesh H. , Aziz, Imran , Black, Christopher J , Corsetti, M , Ford, Alexander C , Whorwell, Peter J , Sperber, Ami D , Vasant, Dipesh H , Houghton, L A , Palsson, Olafur S , Agrawal, Anurag, Bangdiwala, Shrikant I.

Mayo Clinic

Neurogastroenterology & Motility | April 5, 2023 | Volume: 35 | Issue: 6 | Pages: No page available

10.1111/nmo.14574 | PMID 37018424 Get It

AbstractBackgroundThere are minimal epidemiological data comparing the burden of disorders of gut brain interaction (DGBI) in the UK with other countries. We compared the prevalence of DGBI in the UK with other countries that participated in the Rome Foundation Global Epidemiology Study (RFGES) online.MethodsParticipants from 26 countries completed the RFGES survey online including the Rome IV diagnostic questionnaire and an in‐depth supplemental questionnaire with questions about dietary habits. UK sociodemographic and prevalence data were compared with the other 25 countries pooled together.Key ResultsThe proportion of participants with at least one DGBI was lower in UK participants compared with in the other 25 countries (37.6% 95% CI 35.5%–39.7% vs. 41.2%; 95% CI 40.8%–41.6%,p = 0.001). The UK prevalence of 14 of 22 Rome IV DGBI, including irritable bowel syndrome (4.3%) and functional dyspepsia (6.8%), was similar to the other countries. Fecal incontinence, opioid‐induced constipation, chronic nausea and vomiting, and cannabinoid hyperemesis (p < 0.05) were more prevalent in the UK. Cyclic vomiting, functional constipation, unspecified functional bowel disorder, and proctalgia fugax (p < 0.05) were more prevalent in the other 25 countries. Diet in the UK population consisted of higher consumption of meat and milk (p < 0.001), and lower consumption of rice, fruit, eggs, tofu, pasta, vegetables/legumes, and fish (p < 0.001).Conclusions and InferencesThe prevalence and burden of DGBI is consistently high in the UK and in the rest of the world. Opioid prescribing, cultural, dietary, and lifestyle factors may contribute to differences in the prevalence of some DGBI between the UK and other countries.
Ten-Year Changes in Vision, Refractive Error, and Corneal Thickness After Descemet Stripping Automated Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy
Hodge, David O. , Nau, Cherie B. , Patel, Sanjay V , Patel, Sanjay V.

Mayo Clinic

Cornea | April 5, 2023 | Volume: 43 | Issue: 2 | Pages: 233-236

10.1097/ico.0000000000003289 | PMID 37018761 Get It

Purpose: The goal of this study was to determine changes in best-corrected visual acuity (BCVA), refractive error, and central corneal thickness (CCT) during the first decade after Descemet stripping automated endothelial keratoplasty (DSAEK). Methods: Outcomes of all consecutive eyes undergoing DSAEK for Fuchs endothelial corneal dystrophy (FECD) were reviewed; eyes with untreatable comorbidities before DSAEK were excluded. DSAEK was performed through a temporal incision and all eyes were pseudophakic postoperatively. Changes in BCVA, manifest spherical equivalent, manifest cylinder (vector analysis), and CCT were assessed by using generalized estimating equation models. Results: BCVA improved between 6 months (0.18 ± 0.12 logarithm of the minimum angle of resolution (logMAR); Snellen equivalent, 20/30) and 5 years (0.10 ± 0.10 logMAR; 20/25; n = 74, P < 0.001) and then remained stable at 10 years (0.09 ± 0.10 logMAR, n = 48, P = 0.22). There was a myopic shift of −0.20 ± 0.51 D between 6 months and 5 years (n = 65, P = 0.002) that remained stable at 10 years (−0.09 ± 0.44 D; 20/25; n = 34, P = 0.33). Manifest cylinder drifted with-the-rule between 6 months and 5 years (n = 65, P < 0.001) and between 5 and 10 years (n = 34, P < 0.001). CCT was stable between 6 months (672 ± 57 μm) and 5 years (677 ± 55 μm, n = 67, P = 0.47), but increased at 10 years (702 ± 60 μm, n = 39, P = 0.001). Conclusions: Excellent BCVA can be achieved during the first decade after DSAEK for FECD, although improvement seems to plateau after 5 years. Changes in manifest refractive error were not clinically significant. The gradual increase in CCT was consistent with longer-term changes found after other types of keratoplasty.
Sural nerve biopsy utility by masked assessment of individual histologic preparations
Soontrapa, Pannathat , Dyck, P. James B. , Klein, Caroline M., Engelstad, JaNean , Davies, Jenny , Harmsen, William S. , Mandrekar, Jay , Spinner, Robert J. , Shahar, Shelly, Klein, Christopher J , Shelly, Shahar , Ida, Cristiane M. , Klein, Christopher J.

Mayo Clinic

Journal of the Peripheral Nervous System | April 5, 2023 | Volume: 28 | Issue: 2 | Pages: 191-201

10.1111/jns.12545 | PMID 37017656 Get It

AbstractBackground and AimsComprehensive study of sural nerve biopsy utility based on individual histopathologic preparations is lacking. We aimed to quantify the value of different histologic preparations in diagnosis.MethodsOne hundred consecutive sural nerves were studied by standard histological preparations plus graded teased nerve fibers (GTNF), immunohistochemistry, and epoxy‐semithin morphometry. Three examiners scored the individual preparations separately by a questionnaire of neuropathic and interstitial abnormalities, masked to the biopsy number, versus a gold‐standard of all preparations. Multivariate modeling was utilized to determine best approach versus the gold‐standard.ResultsHighest confidence (range 8–9 of 10) and inter‐rater reliability (99%) for fiber abnormalities came from GTNF, and interstitial abnormalities from paraffin stains (range 7–8, 99%). Vasculitic neuropathy associated with GTNF axonal degeneration (moderate to severe 79%) with OR 3.8, 95% CI (1.001–14.7), p = .04, but not significantly with the other preparations. Clinicopathologic diagnoses associated with teased fiber abnormalities in chronic inflammatory demyelinating polyradiculoneuropathy, 80% (8/10); amyloidosis, 50% (1/2); adult‐onset polyglucosan disease 100% (1/1). GTNF and paraffin stains significantly correlated with fiber density determined by morphometric analysis (GTNF: OR 9.9, p < .0001, paraffin: OR 3.8, p = .03). GTNF combined with paraffin sections had highest accuracy for clinicopathologic diagnoses and fiber density with 0.86 C‐stat prediction versus morphometric analysis. Pathological results lead to initiation or changes of immunotherapy in 70% (35/50; initiation n = 22, reduction n = 9, escalation n = 4) with the remaining having alternative intervention or no change.InterpretationNerve biopsy paraffin stains combined with GTNF have highest diagnostic utility, confidence, inter‐rater reliability, improving accuracy for a pathologic diagnosis aiding treatment recommendations. Immunostains and epoxy preparations are also demonstrated useful supporting consensus guidelines. This study provides class II evidence for individual nerve preparation utility.
A five arm natural history study of nasal vestibulitis
Cathcart-Rake, Elizabeth , Zahrieh, David , Smith, Deanne, Young, Susan E. , McCue, Shaylene , Thomé, Stephan D. , Register, Terra, Piens, Jill, Friday, Bret B., Loprinzi, Charles L. , Cathcart-Rake, Elizabeth J , Young, Susan, O'Connor, Amanda, Loprinzi, Charles , Young, Susan, O'Connor, Amanda, Lacouture, Mario E.

Mayo Clinic

Cancer Medicine | April 5, 2023 | Volume: 12 | Issue: 8 | Pages: 9650-9654

10.1002/cam4.5887 | PMID 37017603 Get It

AbstractIntroductionNasal symptoms are frequently reported by patients undergoing chemotherapy.MethodsEligible patients planning to receive paclitaxel, docetaxel, nab‐paclitaxel, bevacizumab without a concomitant taxane, or “other” (non‐taxane, non‐bevacizumab) chemotherapy regimens were invited to participate in this prospective study. Patients reported nasal symptoms prior to each dose of chemotherapy.ResultsThe percentage of patients (95% CI) who reported nasal symptoms was the same for patients who received bevacizumab or nab‐paclitaxel, 82.6% (61.2%, 95.1%). There were no significant differences among the proportions of patients experiencing nasal symptoms within the paclitaxel, nab‐paclitaxel, and bevacizumab cohorts. Patients in the nab‐paclitaxel cohort were more likely to experience symptoms than those in the non‐taxane non‐bevacizumab cohort or docetaxel cohort (p = 0.001, p = 0.001). Patients in the bevacizumab cohort were more likely to experience nasal symptoms than those in the non‐taxane non‐bevacizumab cohort (p = 0.03).ConclusionNasal vestibulitis symptoms are common in patients receiving chemotherapy, especially those receiving paclitaxel, docetaxel, and bevacizumab. Further investigations into treatments of this symptom complex are warranted.
Joint Asian Pacific Association of Gastroenterology (APAGE)–Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia
Wong, Martin C. S. , Chan, Andrew T. , East, James E. , Chiu, Han‐Mo , Makharia, Govind K, Weller, David , Ooi, Choon Jin , Dao, Hang Viet , Emery, Jon , Makmun, Dadang , Chauhan, Ashish , Chan, Francis K L , Wong, Martin C S , Chan, Andrew T , East, James E , Chiu, Han-Mo , Makharia, Govind K , Ooi, Choon Jin , Limsrivilai, Julajak , Ng, Siew C , Chan, Francis K.L. , Saito, Yutaka , Wu, Kaichun , Ali, Raja Affendi Raja , Ng, Siew C.

Mayo Clinic

Gut | April 5, 2023 | Volume: 72 | Issue: 7 | Pages: 1240-1254

10.1136/gutjnl-2023-329429 | PMID 37019620 Get It

Screening for colorectal cancer (CRC) is effective in reducing CRC related mortality. Current screening methods include endoscopy based and biomarker based approaches. This guideline is a joint official statement of the Asian Pacific Association of Gastroenterology (APAGE) and the Asian Pacific Society of Digestive Endoscopy (APSDE), developed in response to the increasing use of, and accumulating supportive evidence for the role of, non-invasive biomarkers for the diagnosis of CRC and its precursor lesions. A systematic review of 678 publications and a two stage Delphi consensus process involving 16 clinicians in various disciplines was undertaken to develop 32 evidence based and expert opinion based recommendations for the use of faecal immunochemical tests, faecal based tumour biomarkers or microbial biomarkers, and blood based tumour biomarkers for the detection of CRC and adenoma. Comprehensive up-to-date guidance is provided on indications, patient selection and strengths and limitations of each screening tool. Future research to inform clinical applications are discussed alongside objective measurement of research priorities. This joint APAGE–APSDE practice guideline is intended to provide an up-to-date guide to assist clinicians worldwide in utilising non-invasive biomarkers for CRC screening; it has particular salience for clinicians in the Asia-Pacific region.
Professional Challenges for United States Hematology/Oncology Trainees during COVID-19
Banerjee, Rahul , Kareff, Samuel A. , Leyfman, Yan , Dhawan, Natasha , Hammons, Lindsay , Desai, Aakash , Velázquez, Ana I. , Nizam, Amanda , Velazquez, Ana I , Desai, Aakash P , Leyfman, Yan , Banerjee, Rahul , Tsang, Mazie

Mayo Clinic

Cancer Investigation | April 5, 2023 | Volume: 41 | Issue: 6 | Pages: 539-547

10.1080/07357907.2023.2199216 | PMID 37017426 Get It

Predictors of hemodynamic response to mitral transcatheter edge‐to‐edge repair
Samimi, Sahar , Ponce, Alejandra Chavez , Alarouri, Hasan S. , Shaer, Ahmed El , Eleid, Mackram F. , Rihal, Charanjit S. , Chavez Ponce, Alejandra , Guerrero, Mayra , Rihal, Charanjit S. , Alkhouli, Mohamad

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 5, 2023 | Volume: 101 | Issue: 6 | Pages: 1120-1127

10.1002/ccd.30646 | PMID 37017419 Get It

AbstractBackgroundImprovement in left atrial pressure (LAP) during transcatheter edge‐to‐edge repair (TEER) is associated with improved outcomes. We sought to investigate the predictors of optimal hemodynamic response to TEER.MethodsWe identified patients who underwent TEER at Mayo Clinic between May 2014 and February 2022. Patients with missing LAP data, an aborted procedure, and those undergoing a concomitant tricuspid TEER were excluded. We performed a logistic regression analysis to identify predictors of optimal hemodynamic response to TEER (defined as LAP ≤ 15 mmHg).ResultsA total of 473 patients were included (Mean age 78.5 ± 9.4 years, 67.2% males). Overall, 195 (41.2%) achieved an optimal hemodynamic response after TEER. Patients who did not achieve an optimal response had higher baseline LAP (20.0 [17–25] vs. 15.0 [12–18] mmHg, p < 0.001), higher prevalence of AF (68.3% vs. 55.9%, p = 0.006), functional MR (47.5% vs. 35.9%, p = 0.009), annular calcification (41% vs. 29.2%, p = 0.02), lower left ventricular EF (55% vs. 58%, p = 0.02), and more frequent postprocedural severe MR (11.9% vs. 5.1%, p = 0.02) and elevated mitral gradient >5 mmHg (30.6% vs. 14.4%, p < 0.001). In the multivariate logistic regression analysis, AF (OR = 0.58; 95% CI = 0.35–0.96; p = 0.03), baseline LAP (OR = 0.80; 95% CI = 0.75–0.84; p < 0.001) and postprocedural mitral gradient <5 mmHg (OR = 0.35; 95% CI = 0.19–0.65; p < 0.001), were independent predictors of achieving an optimal hemodynamic response. In the multivariate model, residual MR was not independently associated with optimal hemodynamic response.ConclusionsOptimal hemodynamic response is achieved in 4 in 10 patients undergoing TEER. AF, higher baseline LAP, and higher postprocedural mitral gradient were negative predictors of optimal hemodynamic response after TEER.
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?
Katamesh, Basant E. , Madany, Maysa , Labieb, Fatma , Abdelaal, Abdelaziz, Abdelaal, Abdelaziz

Mayo Clinic

Expert Review of Vaccines | April 5, 2023 | Volume: 22 | Issue: 1 | Pages: 366-368

10.1080/14760584.2023.2198600 | PMID 37017380 Get It

Diagnosis and Management of Pelvic Venous Disorders: AJR Expert Panel Narrative Review
Knuttinen, M. Grace , Machan, Lindsay, Khilnani, Neil M. , Louie, Michelle , Caridi, T. , Gupta, Ramona , Winokur, Ronald Scott

Mayo Clinic

American Journal of Roentgenology | April 5, 2023 | Volume: 221 | Issue: 5 | Pages: 565-574

10.2214/ajr.22.28796 | PMID 37095667 Get It

Examining Community Clinicians Use of Imaginal Exposure with Childhood Anxiety Disorders
Whiteside, Stephen P. H.

Mayo Clinic

No container title available | April 5, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2763135/v1 | PMID 37066244 Get It

Abstract Although community therapists rarely use exposure when treating youth with anxiety disorders, they are more likely to endorse the use of imaginal exposure, relative to in vivo or interoceptive exposure. Such use of imaginal exposure could reflect a sub-optimal replacement for in vivo exposure or a targeted intervention to address anxiety-provoking thoughts, such as in generalized anxiety disorder. The current study used the survey responses of 178 community-based clinicians to examine these competing hypotheses. The results indicated that therapist endorsement of more clearly defined imaginal exposure was significantly lower than other techniques such as cognitive restructuring or that imaginal exposure was other used instead of more intensive forms of exposures. In addition, most of the endorsed interventions were targeted at helping youth cope with anxiety rather than corrective learning. Alternatively, there was no observed association between imaginal exposure and treatment of general anxiety. These finding suggest that community therapist use of imaginal exposure is suboptimal and unlikely to improve treatment outcomes.